Portal de investigación
Transcriptome-based molecular staging of human stem cell-derived retinal organoids uncovers accelerated photoreceptor differentiation by 9-cis retinal
Autores de CIPF
Participantes ajenos a CIPF
- Kaya, KD
- Chen, HY
- Brooks, MJ
- Kelley, RA
- Shimada, H
- Nagashima, K
- de Val, N
- Drinnan, CT
- Gieser, L
- Kruczek, K
- Li, TS
- Adlakha, YK
- Welby, E
- Swaroop, A
Grupos de Investigación
Abstract
Purpose: Retinal organoids generated from human pluripotent stem cells exhibit considerable variability during differentiation. Our goals are to assess developmental maturity of the neural retina in vitro and design improved protocols based on objective criteria. Methods: We performed transcriptome analyses of developing retinal organoids from human embryonic and induced pluripotent stem cell lines and utilized multiple bioinformatic tools for comparative analysis. Immunohistochemistry, immunoblotting and electron microscopy were employed for validation. Results: We show that the developmental variability in organoids was reflected in gene expression profiles and could be evaluated by molecular staging with the human fetal and adult retinal transcriptome data. We also demonstrate that the addition of 9-cis retinal, instead of the widely used all-trans retinoic acid, accelerated rod photoreceptor differentiation in organoid cultures, with higher rhodopsin expression and more mature mitochondrial morphology evident by day 120. Conclusion: Our studies provide an objective transcriptome-based modality for determining the differentiation state of retinal organoids and for comparisons across different stem cell lines and platforms, which should facilitate disease modeling and evaluation of therapies in vitro.
Datos de la publicación
- ISSN/ISSNe:
- 1090-0535, 1090-0535
- Tipo:
- Article
- Páginas:
- 663-678
- PubMed:
- 31814692
MOLECULAR VISION MOLECULAR VISION
Citas Recibidas en Web of Science: 62
Documentos
- No hay documentos
Métricas
Filiaciones
Proyectos asociados
3D retinas derivadas de células iPS como herramienta para encontrar terapias eficaces para enfermedades hereditarias de la retina
Investigador Principal: DUNJA LUKOVIC
INSTITUTO DE SALUD CARLOS III . 2017
Estudio preclínico de potencias regenerativo de astrocitos derivados de células madre en tratamiento de lesión medular en ratón
Investigador Principal: SLAVEN ERCEG VUKICEVIC
INSTITUTO DE SALUD CARLOS III . 2019
Cerebellar cells derived from induced pluripotent stem cells in 3D culture generated from ARSACS patients as faithful disease model
Investigador Principal: SLAVEN ERCEG VUKICEVIC
FONDATION DE L'ATAXIE CHARLEVOIX-SAGUENAY . 2015